Embolic Protection Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

Embolic Protection Devices Market By Product (Distal Occlusion Devices, Distal Filters, And Proximal Occlusion Devices), By Application (Cardiovascular Disease, Neurovascular Diseases, And Others), By End-User (Hospitals & Clinics, Ambulatory Surgical Centers, And Others), And by geography is expected to grow at a steady CAGR forecast till 2030 owing to the increasing cases of minimally invasive surgery and increasing prevalence of cardiovascular & neurovascular diseases across the globe

The global embolic protection devices market was valued at USD 1.37 billion in 2023, growing at a CAGR of 7.5% during the forecast period from 2024 to 2030 to reach USD 2.11 billion by 2030. The demand for embolic protection devices is primarily being boosted by the increasing figures of cardiovascular diseases such as stroke, stenosis, and others. Further, the rising adoption of advanced and innovative technologies, the increasing demand for minimally invasive therapy, the rising cases of obesity and other risk factors, and the increasing product launches & approval among others are thereby contributing to the overall growth of the embolic protection devices market during the forecast period from 2024-2030.

Embolic Protection Devices Market Dynamics:

The embolic protection devices market is witnessing a positive growth in product demand owing to various factors, one of the key factors is the increase in the prevalence of coronary heart disease, carotid artery disease, and others.

Coronary heart disease occurs when the walls of arteries become furred up with fatty deposits, which is called atherosclerosis, so the increasing cases of arteriosclerosis can ultimately increase the risk of coronary heart disease which require coronary artery bypass surgery for removing extra fat from vessels. While removing this fat, embolic protection devices are used to capture atherothrombotic debris.

The latest study conducted by Heart Research Institute concluded that over the age of 40, people in general good health have about a 50% chance of developing serious atherosclerosis. Therefore, increasing cases of atherosclerosis may cause coronary heart disease which may need coronary artery bypass surgery with this surgery embolic protection device is used to capture atherothrombotic debris. Thus, increasing cases of atherosclerosis may ultimately increase the demand for embolic protection devices in the market.

Further, the increasing prevalence of obesity is a major health concern that can lead to atherosclerosis. For instance, according to World Health Organization (WHO) 2022, obesity has reached epidemic proportions globally, with at least 2.8 million people dying each year as a result of being overweight or obese. Also, as per UK Parliament January 2023, in 2022, 26% of adults in England were obese and 38% were overweight. Obese and overweight people are at high risk for atherosclerosis as the extra fat may cause angina or stroke which is removed through atherectomy. In the procedure of atherectomy, doctors use an embolic protection device to capture luminal debris which prevents embolization. Thus, the increasing prevalence of obesity can lead to atherosclerosis which may need surgery for fat deposition, ultimately driving the demand for embolic protection devices, thereby increasing the overall market growth of the embolic protection device.

Coupled with the factors mentioned above, strategic activities such as product launches & approvals, increasing research, and others will also contribute to the growth of the embolic protection devices market during the forecast period from 2024-2030. For instance, Emboline, a medical device company invested $55 million to develop an embolic protection device. The device designed by the company helps to provide complete embolic protection of the brain and other critical organs by capturing and removing emboli produced during a surgical procedure.

Therefore, the aforementioned factors will propel the overall market growth of embolic protection devices during the forecast period from 2024-2030.

However, the availability of alternative devices and others may restrict the embolic protection devices market growth.

The embolic protection devices market was negatively impacted during the period of COVID- 19 pandemic. The outbreak of the pandemic led to the cancellation of outpatient visits, the suspension of non-emergency hospital visits, and the cancellation of surgical procedures. This resulted in a reduction in the number of patients for routine treatments of chronic disorders such as cancers, diabetes, cardiovascular disorders, stroke, and others. Moreover, many elective surgeries were postponed as treatment of patients suffering from coronavirus infection was on priority. Additionally, the restrictions on the supply chain, raw materials, and other resources halted the manufacturing of devices, leading to a shortage of treatment devices in the market. However, the vaccine development of COVID-19 initiated the process of economic recovery. Also, the easing of lockdown restrictions and the return of normalcy in the economic landscape initiated the process of resumption of regular healthcare services such as outpatient visits and surgeries for the treatment of aforementioned ailments, thereby bringing the demand for products on track in the embolic protection device market.

Embolic Protection Devices Market Segment Analysis:

Embolic Protection Devices by Product (Distal Occlusion Devices, Distal Filters, and Proximal Occlusion Devices), Application (Cardiovascular Disease, Neurovascular Diseases, and Others), End-User (Hospitals & Clinics, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product segment of the embolic protection devices market, the distal filters category is expected to amass significant revenue share in the year 2023 because of their easy maintenance, easy use, and others.

For instance, cerebral thrombosis is the most common type of ischemic stroke in which blood clot forms inside a diseased or damaged artery in the brain resulting from atherosclerosis (cholesterol-containing deposits called plaque), blocking blood flow. These risks are minimized using small filters called distal filter embolic protection devices in conjunction with angioplasty and stenting.

Furthermore, the growth of distal filter embolic protection devices is increasing due to cardiovascular diseases such as heart attack, stroke, and others. For instance, according to the World Heart Federation 2022, 85% of the 18 million cardiovascular deaths occur annually due to ASCVD (atherosclerosis and atherosclerotic cardiovascular diseases). Coronary heart disease may cause stenosis (narrowing) in one or more arteries. These increasing cases of mortality can be controlled by performing coronary artery bypass surgery at an apt time. During the coronary artery bypass surgery procedure, embolization of arteries can occur due to atheromatous plaques, thus, to prevent this, a distal embolic protection device is used during surgery for trapping debris.

Thus, the rise in the cases of cardiovascular cases will increase the number of coronary artery bypass surgery, which will ultimately increase the demand for embolic protection devices.

Therefore, the above-mentioned factor, the advantages offered by distal filter devices over others are predicted to contribute to the increasing demand for this segment type. Thereby driving the growth of the overall embolic protection devices market during the forecast period.

North America is expected to dominate the overall Embolic Protection Devices Market:

Among all the regions, North America is estimated to account for the largest share of the embolic protection devices market in the year 2023. Owing to the significance of key growth factors such as the rising cases of coronary heart disease and carotid artery disease, increasing obesity among people, and other factors are driving the North American embolic protection devices market and are expected to witness positive growth. Furthermore, the high disposable income, sophisticated healthcare infrastructure, rising regulatory approval for new products, and high awareness about minimally invasive surgery will also help the market growth in this region.

According to the Centers for Disease and Prevention Control (CDC) 2020, coronary heart disease is the most common type of heart disease in the US and accounted for 382,820 deaths in 2020. From the same source 2022, in the United States, every year, about 805,000 people had a heart attack, out of these, 605,000 were their first heart attack, and 200,000 happened to people who have already had a heart attack each year.

As per CDC (2023), almost 2 in 5 adults in the United States have high cholesterol (total blood cholesterol = 200 mg/dL) each year which can put a person at risk for heart disease and stroke. Thus, the increasing cases of heart attack and stroke may need an angioplasty to remove thrombus, blocks, or plugs from the artery. Angioplasty is a procedure in which a balloon or stent is used to open a narrowed or blocked artery, along with an embolic protection device to trap blood and luminal debris so that debris cannot go forward with the blood flow. Thus, increasing cases of heart attack and stroke in the US may increase the need for angioplasty which will ultimately be leading to increasing demand for distal embolic protection devices in the region.

Therefore, the aforementioned factors above would provide a growth environment for the North American region in the embolic protection device market.

Embolic Protection Devices Market Key Players:

Some of the key market players operating in the embolic protection devices market include Boston Scientific Corporation, Abbott, Medtronic, Cordis, Contego Medical, inc., Integer Holdings Corporation, InspireMD Inc, Emboline, Inc., Keystone Heart Ltd., and others.

Recent Developmental Activities in the Embolic Protection Devices Market:

In October 2020, Keystone Heart Ltd., a Venus Medtech Company, announced that the TriGUARD 3 Cerebral Embolic Protection (CEP) Device received European CE certification. This device is developed to reduce the risk of stroke by trapping embolic particles away from the brain.

In February 2020, FDA approved a temporary catheter by Boston Scientific Corporation for embolic protection during Transcatheter intracardiac procedures.

Key Takeaways from the Embolic Protection Devices Market Report Study

Market size analysis for current embolic protection devices market size (2023), and market forecast for 5 years (2024-2030)

Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years

Key companies dominating the global embolic protection devices market.

Various opportunities are available for the other competitor in the embolic protection devices market space.

What are the top-performing segments in 2023? How these segments will perform in 2030.

Which are the top-performing regions and countries in the current embolic protection devices market scenario?

Which are the regions and countries where companies should have concentrated on opportunities for embolic protection devices market growth in the coming future?

Target Audience who can be benefited from this Embolic Protection Devices Market Report Study

Embolic protection devices products providers

Research organizations and consulting companies

Embolic protection devices-related organizations, associations, forums, and other alliances

Government and corporate offices

Start-up companies, venture capitalists, and private equity firms

Distributors and Traders dealing in embolic protection devices

Various End-users who want to know more about the embolic protection devices market and the latest technological developments in the embolic protection devices market.

Frequently Asked Questions for the Embolic Protection Devices Market:

1. What are embolic protection devices?

Embolic protection devices (EPD) are catheter-based devices used to capture atherothrombotic debris which is used during percutaneous vascular interventions to reduce the number of complications due to debris, which can be released into the bloodstream and can cause blockages in smaller vessels.

2. What is the market for global embolic protection devices?

The global embolic protection devices market was valued at USD 1.37 billion in 2023, growing at a CAGR of 7.5% during the forecast period from 2024 to 2030 to reach USD 2.11 billion by 2030.

3. What are the drivers for global embolic protection devices market?

The demand for embolic protection devices is primarily being heightened by the increasing prevalence of cardiovascular diseases and neurovascular diseases such as carotid artery disease, coronary artery disease, stroke, and others. In addition, the advancement in embolic protection devices that aid in improving the efficiency of the minimally invasive technique, increasing device launches and approvals, among others thereby contribute to the overall growth of the embolic protection devices market during the forecast period from 2024-2030.

4. Who are the key players operating in the global embolic protection devices market?

Some of the key market players operating in the embolic protection devices market include Boston Scientific Corporation, Abbott, Medtronic, Cordis, Contego Medical, Inc., Integer Holdings Corporation, InspireMD Inc, Emboline, Inc., Keystone Heart Ltd., and others.

5. Which region has the highest share in the embolic protection devices market?

North America is expected to dominate the overall embolic protection devices market during the forecast period from 2024-2030. Owing to the factors such as the rising prevalence of cardiovascular disorders, the growing cases of obesity, the rising geriatric population in the region, and others will increase the North American embolic protection devices market. Furthermore, high disposable income, sophisticated healthcare infrastructure, regulatory approval for new devices, and high awareness about embolic protection diseases also helped the market growth in this region.